Skip to content

Wednesday, October 28, 2026

Data from SEC filings, checked daily

Public filings, plainly told

About Method Sources Newsletter

Insider tradingForm 4

Spyre Therapeutics, Inc. (SYRE) Insider Trading

9 open-market trades reported since Sep 3, 2026: 0 purchases worth $0 and 9 sales worth $12.3M.

By insider

Insider	Role	Buys	Bought	Sells	Sold	Latest
Heidy King-Jones	See Remarks	0	$0	3	$5.11M	Oct 2, 2026
Scott L. Burrows	CFO	0	$0	4	$4.55M	Oct 2, 2026
Cameron Turtle	CEO	0	$0	2	$2.69M	Oct 2, 2026

All trades

SYRE insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	3 mo. after	Filing
Oct 2	Oct 1	Heidy King-JonesSee Remarks	See Remarks	▼ SELL10b5-1	28,933	91.03	$2.63M	−91%		Form 4 ↗
Oct 2	Sep 30	Scott L. BurrowsCFO	CFO	▼ SELL10b5-1	17,500	89.89	$1.57M	−18%		Form 4 ↗
Oct 2	Oct 1	Cameron TurtleCEO	CEO	▼ SELL10b5-1	15,000	92.01	$1.38M	−2.7%		Form 4 ↗
Oct 2	Oct 1	Scott L. BurrowsCFO	CFO	▼ SELL10b5-1	7,500	91.83	$689K	−8.6%		Form 4 ↗
Sep 3	Sep 1	Heidy King-JonesSee Remarks	See Remarks	▼ SELL10b5-1	27,999	87.31	$2.44M	−91%		Form 4 ↗
Sep 3	Sep 2	Scott L. BurrowsCFO	CFO	▼ SELL10b5-1	18,232	89.35	$1.63M	−19%		Form 4 ↗
Sep 3	Sep 1	Cameron TurtleCEO	CEO	▼ SELL10b5-1	15,000	87.29	$1.31M	−2.6%		Form 4 ↗
Sep 3	Sep 1	Scott L. BurrowsCFO	CFO	▼ SELL10b5-1	7,500	87.31	$655K	−7.1%		Form 4 ↗
Sep 3	Sep 2	Heidy King-JonesSee Remarks	See Remarks	▼ SELL10b5-1	400	90.00	$36K	−12%		Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings